Document:

Exhibit
4.13

 

BYND
CANNASOFT ENTERPRISES INC.

 

STOCK
OPTION PLAN

 

	1.	The
                                            Plan

 

A
stock option plan (the “Plan”), pursuant to which options to purchase common shares, or such other shares as may be
substituted therefor (“Shares”), in the capital of BYND Cannasoft Holdings Ltd. (the “Corporation”)
may be granted to the directors, officers and employees of the Corporation and to consultants retained by the Corporation, is hereby
established on the terms and conditions set forth herein.

 

	2.	Purpose

 

The
purpose of this Plan is to advance the interests of the Corporation by encouraging the directors, officers and employees of the Corporation
or any of its subsidiaries and consultants retained by the Corporation or any of its subsidiaries to acquire Shares, thereby: (i) increasing
the proprietary interests of such persons in the Corporation; (ii) aligning the interests of such persons with the interests of the Corporation’s
shareholders generally; (iii) encouraging such persons to remain associated with the Corporation or any of its subsidiaries and (iv)
furnishing such persons with an additional incentive in their efforts on behalf of the Corporation or any of its subsidiaries.

 

	3.	Administration
                                            

 

		(a)	This
                                            Plan shall be administered by the board of directors of the Corporation (the “Board”).

 

		(b)	Subject
                                            to the terms and conditions set forth herein, the Board is authorized to provide for the
                                            granting, exercise and method of exercise of Options (as defined in paragraph 3(d) below),
                                            all on such terms (which may vary between Options granted from time to time) as it shall
                                            determine. In addition, the Board shall have the authority to: (i) construe and interpret
                                            this Plan and all option agreements entered into hereunder; (ii) prescribe, amend and rescind
                                            rules and regulations relating to this Plan and (iii) make all other determinations necessary
                                            or advisable for the administration of this Plan. All determinations and interpretations
                                            made by the Board shall be binding on all Participants (as hereinafter defined) and on their
                                            legal, personal representatives and beneficiaries.

 

		(c)	Notwithstanding
                                            the foregoing or any other provision contained herein, the Board shall have the right to
                                            delegate the administration and operation of this Plan, in whole or in part, to a committee
                                            of the Board or to the President or any other officer of the Corporation. Whenever used herein,
                                            the term “Board” shall be deemed to include any committee or officer to which
                                            the Board has, fully or partially, delegated responsibility and/or authority relating to
                                            the Plan or the administration and operation of this Plan pursuant to this Section 3.

 

    	 

    	- 2 -

    

 

		(d)	Options
                                            to purchase the Shares granted hereunder (“Options”) shall be evidenced
                                            by (i) an agreement that may vary between Participants (as hereinafter defined), signed on
                                            behalf of the Corporation and by the person to whom an Option is granted, which agreement
                                            shall be in such form as the Board shall approve, or (ii) a written notice or other instrument,
                                            signed by the Corporation, setting forth the material attributes of the Options.

 

		(e)	Notwithstanding
                                            the foregoing, the additional provisions set forth in Appendix “A” attached hereto
                                            entitled “Provisions Applicable to Residents of Israel” shall apply to those
                                            Participants (as hereinafter defined) who are resident in the State of Israel (Participants
                                            who are residents of Israel are referred to herein as “Israeli Participants”).

 

	4.	Shares
                                            Subject to Plan

 

		(a)	Subject
                                            to Section 15 below, the securities that may be acquired by Participants (as defined in paragraph
                                            6(a) below) upon the exercise of Options shall be deemed to be fully authorized and issued
                                            Shares of the Corporation. Whenever used herein, the term “Shares” shall be deemed
                                            to include any other securities that may be acquired by a Participant upon the exercise of
                                            an Option the terms of which have been modified in accordance with Section 15 below.

 

		(b)	The
                                            aggregate number of Shares reserved for issuance under this Plan, or any other plan of the
                                            Corporation, shall not, at the time of the stock option grant, exceed ten percent (10%) of
                                            the total number of issued and outstanding Shares (calculated on a non-diluted basis) unless
                                            the Corporation receives the permission of the stock exchange or exchanges on which the Shares
                                            are then listed to exceed such threshold.

 

		(c)	If
                                            any Option granted under this Plan shall expire or terminate for any reason without having
                                            been exercised in full, any un-purchased Shares to which such Option relates shall be available
                                            for the purposes of the granting of Options under this Plan.

 

	5.	Maintenance
                                            of Sufficient Capital

 

The
Corporation shall at all times during the term of this Plan ensure that the number of Shares it is authorized to issue shall be sufficient
to satisfy the Corporation’s obligations under all outstanding Options granted pursuant to this Plan.

 

	6.	Eligibility
                                            and Participation

 

		(a)	The
                                            Board may, in its discretion, select any of the following persons to participate in this
                                            Plan:

 

		(i)	directors of the Corporation or any of its subsidiaries (or, in the case of an Israeli Participant, their trustees);

 

    	 

    	- 3 -

    

 

		(ii)	officers
                                            of the Corporation or any of its subsidiaries (or, in the case of an Israeli Participant,
                                            their trustees);

 

		(iii)	employees
                                            of the Corporation or any of its subsidiaries (or, in the case of an Israeli Participant,
                                            their trustees); and

 

		(iv)	consultants
                                            retained by the Corporation or any of its subsidiaries (or, in the case of an Israeli Participant,
                                            their trustees), provided such consultants have performed and/or continue to perform services
                                            for the Corporation or any of its subsidiaries on an ongoing basis or are expected to provide
                                            a service of value to the Corporation or any of its subsidiaries;

 

(any
such person having been selected for participation in this Plan by the Board is herein referred to as a “Participant”).

 

		(b)	The
                                            Board may from time to time, in its discretion, grant an Option to any Participant, upon
                                            such terms, conditions and limitations as the Board may determine, including the terms, conditions
                                            and limitations set forth herein, provided that Options granted to any Participant shall
                                            be approved by the shareholders of the Corporation if the rules of any stock exchange on
                                            which the Shares are listed require such approval.

 

		(c)	The
                                            Corporation represents that, for any Options granted to an officer, employee or consultant
                                            of the Corporation or any of its subsidiaries, such Participant is a bona fide officer,
                                            employee or consultant of the Corporation or of such subsidiary.

 

	7.	Exercise
                                            Price

 

The
Board shall, at the time an Option is granted under this Plan, fix the exercise price at which Shares may be acquired upon the exercise
of such Option provided that such exercise price shall not be less than that from time to time permitted under the rules of any stock
exchange or exchanges on which the Shares are then listed. In addition, the exercise price of an Option must be paid in cash. Disinterested
shareholder approval shall be obtained by the Corporation prior to any reduction to the exercise price if the affected Participant is
an insider (as defined in the Securities Act (British Colimbia) of the Corporation at the time of the proposed amendment.

 

	8.	Number
                                            of Optioned Shares

 

The
number of Shares that may be acquired under an Option granted to a Participant shall be determined by the Board as at the time the Option
is granted, provided that the aggregate number of Shares reserved for issuance to any one Participant under this Plan or any other plan
of the Corporation, shall not exceed five percent of the total number of issued and outstanding Shares (calculated on a non-diluted basis)
in any 12 month period unless the Corporation receives the permission of the stock exchange or exchanges on which the Shares are listed
to exceed such threshold and provided further that the number of Options granted to any one consultant in a 12 month period shall not
exceed 2% of the total number of issued and outstanding Shares and the aggregate number of Options granted to persons employed to provide
investor relations activities shall not exceed 2% of the total number of issued and outstanding Shares in any 12 month period. The Corporation
shall obtain disinterested shareholder approval for grants of Options to insiders (as defined in the Securities Act (British Columbia)),
of a number of Options exceeding 10% of the issued Shares, within any 12 month period.

 

    	 

    	- 4 -

    

 

	9.	Term

 

The
period during which an Option may be exercised (the “Option Period”) shall be determined by the Board at the time
that the Option is granted, subject to any vesting limitations which may be imposed by the Board in its sole unfettered discretion at
the time that such Option is granted and Sections 11, 12, and 16 provided that:

 

		(a)	no
                                            Option shall be exercisable for a period exceeding ten (10) years from the date that the
                                            Option is granted;

 

		(b)	no
                                            Option in respect of which shareholder approval is required under the rules of any stock
                                            exchange or exchanges on which the Shares are then listed shall be exercisable until such
                                            time as the Option has been approved by the shareholders of the Corporation;

 

		(c)	the
                                            Board may, subject to the receipt of any necessary regulatory approvals, in its sole discretion,
                                            accelerate the time at which any Option may be exercised, in whole or in part; and

 

		(d)	any
                                            Options granted to any Participant must expire within 90 days after the Participant ceases
                                            to be a Participant, and within 30 days for any Participant engaged in investor relation
                                            activities after such Participant ceases to be employed to provide investor relation activities.

 

	10.	Method
                                            of Exercise of Option

 

		(a)	Except
                                            as set forth in Sections 11 and 12 below or as otherwise determined by the Board, no Option
                                            may be exercised unless the holder of such Option is, at the time the Option is exercised,
                                            a director, officer, employee or consultant of the Corporation or any of its subsidiaries
                                            or, in the case of an Israeli Participant, a trustee of an Israeli Participant who is, at
                                            the time the Option is exercised, a director, officer, employee or consultant of the Corporation
                                            or any of its subsidiaries;

 

		(b)	Options
                                            that are otherwise exercisable in accordance with the terms thereof may be exercised in whole
                                            or in part from time to time;

 

		(c)	Any
                                            Participant (or his legal, personal representative) wishing to exercise an Option shall deliver
                                            to the Corporation, at its principal office in the City of Vancouver, British Columbia:

 

	 	(i)	a
                                            written notice expressing the intention of such Participant (or his legal, personal representative)
                                            to exercise his Option and specifying the number of Shares in respect of which the Option
                                            is exercised; and

 

    	 

    	- 5 -

    

 

		(ii)	a
                                            cash payment, certified cheque or bank draft, representing the full purchase price of the
                                            Shares in respect of which the Option is exercised.

 

		(d)	Upon
                                            the exercise of an Option as aforesaid, the Corporation shall use reasonable efforts to forthwith
                                            deliver, or cause the registrar and transfer agent of the Shares to deliver, to the relevant
                                            Participant (or his legal, personal representative) or to the order thereof, a certificate
                                            representing the aggregate number of fully paid and non-assessable Shares in respect of which
                                            the Option has been duly exercised.

 

	11.	Ceasing
                                            to be a Director, Officer, Employee or Consultant

 

If
any Participant shall cease to hold the position or positions of director, officer, employee or consultant of the Corporation or any
of its subsidiaries (as the case may be) for any reason other than death, his Option will terminate at 4:00 p.m. (Toronto time) on the
earlier of the date of the expiration of the Option Period and 60 days after the date such Participant ceases to hold the position or
positions of director, officer, employee or consultant of the Corporation or any of its subsidiaries as the case may be, and ceases to
actively perform services for the Corporation or any of its subsidiaries. An Option granted to a Participant who performs investor relations
services on behalf of the Corporation or any of its subsidiaries shall terminate on the date of termination of the employment or cessation
of services being provided and shall be subject to Exchange policies and procedures for the termination of Options for investor relations
services. For greater certainty, the termination of any Options held by the Participant, and the period during which the Participant
may exercise any Options, shall be without regard to any notice period arising from the Participant’s ceasing to hold the position
or positions of director, officer, employee or consultant of the Corporation or any of its subsidiaries (as the case may be).

 

Neither
the selection of any person as a Participant nor the granting of an Option to any Participant under this Plan shall: (i) confer upon
such Participant any right to continue as a director, officer, employee or consultant of the Corporation or any of its subsidiaries,
as the case may be; or (ii) be construed as a guarantee that the Participant will continue as a director, officer, employee or consultant
of the Corporation or any of its subsidiaries, as the case may be.

 

With
regard to Options held by a trustee of an Israeli Participant, this Section will apply to the Israeli Participants.

 

	12.	Death
                                            of a Participant

 

In
the event of the death of a Participant, any Option previously granted to him shall be exercisable until the end of the Option Period
or until the expiration of 12 months after the date of death of such Participant, whichever is earlier, and then, in the event of death,
only:

 

	 	(a)	by the person or persons to whom the Participant’s rights under the
Option shall pass by the Participant’s will or applicable law; and

 

    	 

    	- 6 -

    

  

		(b)	to
                                            the extent that he was entitled to exercise the Option as at the date of his death.

 

With
regard to Options held by a trustee of an Israeli Participant, this Section will apply to the Israeli Participants.

 

	13.	Rights
                                            of Participants

 

No
person entitled to exercise any Option granted under this Plan shall have any of the rights or privileges of a shareholder of the Corporation
in respect of any Shares issuable upon exercise of such Option until such Shares have been paid for in full and issued to such person.

 

	14.	Proceeds
                                            from Exercise of Options

 

The
proceeds from any sale of Shares issued upon the exercise of Options shall be added to the general funds of the Corporation and shall
thereafter be used from time to time for such corporate purposes as the Board may determine and direct.

 

	15.	Adjustments

 

		(a)	The
                                            number of Shares subject to the Plan shall be increased or decreased proportionately in the
                                            event of the subdivision or consolidation of the outstanding Shares of the Corporation, and
                                            in any such event a corresponding adjustment shall be made to the number of Shares deliverable
                                            upon the exercise of any Option granted prior to such event without any change in the total
                                            price applicable to the unexercised portion of the Option, but with a corresponding adjustment
                                            in the price for each Share that may be acquired upon the exercise of the Option. In case
                                            the Corporation is reorganized or merged or consolidated or amalgamated with another corporation,
                                            appropriate provisions shall be made for the continuance of the Options outstanding under
                                            this Plan and to prevent any dilution or enlargement of the same.

 

		(b)	Adjustments
                                            under this Section 15 shall be made by the Board, whose determination as to what adjustments
                                            shall be made, and the extent thereof, shall be final, binding and conclusive. No fractional
                                            Shares shall be issued upon the exercise of an Option following the making of any such adjustment.

 

	16.	Change
                                            of Control

 

Notwithstanding
the provisions of section 11 or any vesting restrictions otherwise applicable to the relevant Options, in the event of a sale by the
Corporation of all or substantially all of its assets or in the event of a change of control of the Corporation, each Participant shall
be entitled to exercise, in whole or in part, the Options granted to such Participant hereunder, either during the term of the Option
or within 90 days after the date of the sale or change of control, whichever first occurs.

 

    	 

    	- 7 -

    

 

For
the purpose of this Plan, “change of control of the Corporation” means and shall be deemed to have occurred upon:

 

		(a)	the
                                            acceptance by the holders of Shares of the Corporation, representing in the aggregate, more
                                            than 50 percent of all issued Shares of the Corporation, of any offer, whether by way of
                                            a takeover bid or otherwise, for all or any of the outstanding Shares of the Corporation;
                                            or

 

		(b)	the
                                            acquisition, by whatever means, by a person (or two or more persons who, in such acquisition,
                                            have acted jointly or in concert or intend to exercise jointly or in concert any voting rights
                                            attaching to the Shares acquired), directly or indirectly, of beneficial ownership of such
                                            number of Shares or rights to Shares of the Corporation, which together with such person’s
                                            then owned Shares and rights to Shares, if any, represent (assuming the full exercise of
                                            such rights to voting securities) more than fifty percent (50%) of the combined voting rights
                                            of the Corporation’s then outstanding Shares; or

 

		(c)	the
                                            entering into of any agreement by the Corporation to merge, consolidate, amalgamate, initiate
                                            an arrangement or be absorbed by or into another corporation; or

 

		(d)	the
                                            passing of a resolution by the Board or shareholders of the Corporation to substantially
                                            liquidate the assets or wind-up the Corporation’s business or significantly rearrange
                                            its affairs in one or more transactions or series of transactions or the commencement of
                                            proceedings for such a liquidation, winding-up or re-arrangement (except where such re-arrangement
                                            is part of a bona fide reorganization of the Corporation in circumstances where the business
                                            of the Corporation is continued and where the shareholdings remain substantially the same
                                            following the re-arrangement); or

 

		(e)	individuals
                                            who were members of the Board of the Corporation immediately prior to a meeting of the shareholders
                                            of the Corporation involving a contest for or an item of business relating to the election
                                            of directors, not constituting a majority of the Board following such election.

 

	17.	Transferability

 

All
benefits, rights and Options accruing to any Participant in accordance with the terms and conditions of this Plan shall be non-transferrable
and non-assignable unless specifically provided herein. However, a trustee of an Israeli Participant may transfer such benefits, rights
and Options to the Israeli Participant for whom it is acting as trustee.

 

During
the lifetime of a Participant, any Options granted hereunder may only be exercised by the Participant and in the event of the death of
a Participant, by the person or persons to whom the Participant’s rights under the Option pass by the Participant’s will
or applicable law. With regard to Options held by a trustee of an Israeli Participant, the preceding sentence with apply to the Israeli
Participant for whom the trustee holds the Options.

 

    	 

    	- 8 -

    

 

	18.	Amendment
                                            and Termination of Plan

 

The
Board may, at any time, suspend or terminate this Plan. The Board may also, at any time, amend or revise the terms of this Plan, subject
to the receipt of all necessary regulatory approvals, provided that no such amendment or revision shall alter the terms of any Options
theretofore granted under this Plan.

 

	19.	Necessary
                                            Approvals

 

The
obligation of the Corporation to issue and deliver Shares in accordance with this Plan and Options granted hereunder is subject to applicable
securities legislation and to the receipt of any approvals that may be required from any regulatory authority or stock exchange having
jurisdiction over the securities of the Corporation. If Shares cannot be issued to a Participant upon the exercise of an Option for any
reason whatsoever, the obligation of the Corporation to issue such Shares shall terminate and any funds paid to the Corporation in connection
with the exercise of such Option will be returned to the relevant Participant as soon as practicable.

 

	20.	Stock
                                            Exchange Rules

 

This
Plan and any option agreements entered into hereunder shall comply with the requirements from time to time of the stock exchange or exchanges
on which the Shares are listed.

 

	21.	Right
                                            to Issue Other Shares

 

The
Corporation shall not by virtue of this Plan be in any way restricted from declaring and paying stock dividends, issuing further Shares,
varying or amending its share capital or corporate structure or conducting its business in any way whatsoever.

 

	22.	Notice

 

Any
notice required to be given by this Plan shall be in writing and shall be given by registered mail, postage prepaid or delivered by courier
or by facsimile transmission addressed, if to the Corporation, at its principal address in Vancouver, British Columbia (Attention: CFO);
or if to a Participant, to such Participant at his address as it appears on the books of the Corporation or in the event of the address
of any such Participant not so appearing then to the last known address of such Participant; or if to any other person, to the last known
address of such person.

 

	23.	Gender

 

Whenever
used herein words importing the masculine gender shall include the feminine and neuter genders and vice versa.

 

	24.	Interpretation

 

This
Plan will be governed by and construed in accordance with the laws of the Province of British Columbia, except for Appendix “A”,
which will be governed and construed in accordance with the laws of the State of Israel.

 

DATE
OF PLAN: This Stock Option Plan is dated for reference as of March 29, 2021.

 

    	 

    	- 9 -

    

 

APPENDIX
“A” 

 

Provisions
Applicable to Residents of Israel 

 

	1.	Administration
                                            

 

		(a)	Without
                                            limiting the generality of Section 3 of the Plan, with respect to any Israeli Participants,
                                            the Board shall have the full authority, pursuant to the general terms and conditions of
                                            the Plan and the provisions of either Section 102 or Section 3(9) of the Israeli Income Tax
                                            Ordinance [New Version] 1961 (the “Ordinance”), in its discretion, from
                                            time to time and at any time, to determine:

 

		(i)	with
                                            respect to the grant of 102 Options (as defined in Section 2(a)(i) of this Appendix) - whether
                                            the Corporation shall elect the “Ordinary Income Route” under Section
                                            102(b)(1) of the Ordinance (the “Ordinary Income Route”) or the
                                            “Capital Gains Route” under Section 102(b)(2) of the Ordinance (the “Capital
                                            Gains Route”) (each a “Taxation Route”) for the grant of 102
                                            Options, and the identity of the trustee who shall be granted such 102 Options in accordance
                                            with the provisions of this Plan and the then prevailing Taxation Route. In the event the
                                            Board determines that the Corporation shall elect one of the Taxation Routes for the grant
                                            of 102 Options, the Corporation shall be entitled to change such election only following
                                            the lapse of one year from the end of the tax year in which 102 Options are first granted
                                            under the then prevailing Taxation Route, unless permitted to change such election earlier
                                            in accordance with the Ordinance or applicable regulations; and

 

		(ii)	with
                                            respect to the grant of 3(9) Options (as defined in Section 2(a)(ii) of this Appendix) -
                                            whether or not 3(9) Options (as defined in section 2(a)(ii) of this Appendix) shall be granted
                                            to a trustee in accordance with the terms and conditions of this Plan, and the identity of
                                            the trustee who shall be granted such 3(9) Options in accordance with the provisions of this
                                            Plan.

 

		(b)	Notwithstanding
                                            the aforesaid, the Board may, from time to time and at any time, grant 102 Options that will
                                            not be subject to a Taxation Route, as detailed in Section 102(c) of the Ordinance (“102(c)
                                            Options”).

 

	2.	Grant
                                            of Options and Issuance of Shares

 

Subject
to the provisions of the Ordinance and applicable law,

 

		(a)	all
                                            grants of Options to Israeli Participants who are employees, directors or officers of the
                                            Corporation or any of its subsidiaries, other than to a Controlling Shareholder of the Corporation
                                            (i.e., “Baal Shlita”, as such term is defined in the Ordinance), (a “102
                                            Participant”) shall be made only pursuant to the provisions of Section 102 of the
                                            Ordinance, the Income Tax Rules (Tax Relief in Issuance of Shares to Employees), 2003 (“102
                                            Rules”) and any other regulations, rulings, procedures or clarifications promulgated
                                            under Section 102 (“102 Options”), or any other section of the Income
                                            Tax Ordinance that will be relevant for such issuance in the future, all as they may be amended
                                            or superceded from time to time; and

 

    	 

    	- 10 -

    

 

		(b)	all
                                            grants of Options to Israeli Participants who are consultants, contractors or Controlling
                                            Shareholders of the Corporation or any of its subsidiaries shall be made only pursuant to
                                            the provisions of Section 3(9) of the Ordinance and the rules and regulations promulgated
                                            thereunder (“3(9) Options”), or any other section of the Ordinance that
                                            will be relevant for such issuance in the future.

 

	3.	Trust
                                            

 

		(a)	In
                                            the event Options are granted under the Plan to a trustee designated by the Board in accordance
                                            with the provisions of Section 1(a) of this Appendix and, with respect to 102 Options, approved
                                            by the Israeli Commissioner of Income Tax (the “Trustee”), the Trustee
                                            shall hold each such Option and the Shares issued upon exercise thereof in trust (the “Trust”)
                                            for the benefit of the Participant in respect of whom such Option was granted (the “Beneficial
                                            Participant”).

 

		(b)	In
                                            accordance with Section 102, the tax benefits afforded to 102 Options (and any Shares received
                                            upon exercise thereof) in accordance with the Ordinary Income Route or Capital Gains Route,
                                            as applicable, shall be contingent upon a Trustee holding such 102 Options for a period of
                                            at least (i) one year from when the 102 Options are granted, if the Corporation elects the
                                            Ordinary Income Route, or (ii) two years when the 102 Options are granted, if the Corporation
                                            elects the Capital Gains Route, or (iii) such other period as shall be determined by the
                                            Ordinance and applicable regulations or shall be approved by the Israeli Commissioner of
                                            Income Tax (collectively the “Trust Period”).

 

		(c)	With
                                            respect to 102 Options granted to the Trustee, the following shall apply:

 

		(i)	A
                                            102 Participant shall not be entitled to receive from the Trustee the Options granted to
                                            him or her, exercise such Options, sell the Shares received upon exercise thereof (the “Exercised
                                            Shares”) or transfer such Exercised Shares (or such 102 Options) from the Trust
                                            prior to the lapse of the Trust Period, unless the Notice of Grant or the Board specify otherwise.

 

		(ii)	Any
                                            and all rights issued in respect of the Exercised Shares, including bonus shares but excluding
                                            cash dividends (“Rights”), shall be issued to the Trustee and held until
                                            the lapse of the Trust Period, and such Rights shall be subject to the Taxation Route which
                                            is applicable to such Exercised Shares.

 

		(iii)	Notwithstanding
                                            the aforesaid, Options may be received or exercised, Exercised Shares or Rights may be sold
                                            or transferred and the Trustee may release such Exercised Shares (or 102 Options) or Rights
                                            from Trust, prior to the lapse of the Trust Period, provided that (i) the Board agrees to
                                            such release, exercise or sale and (ii) tax is paid or withheld in accordance with Section
                                            102(b)(4) of the Ordinance and Section 7 of the 102 Rules as they may be amended or superseded.
                                            The Board may withhold or condition its agreement in its absolute discretion, inter alia,
                                            to incentivize a 102 Participant to continue his or her employment until the end of the Trust
                                            Period.

 

    	 

    	- 11 -

    

 

		(iv)	All
                                            certificates representing Shares issued to the Trustee under the Plan shall be deposited
                                            with the Trustee, and shall be held by the Trustee until such time that such Shares are released
                                            from the Trust as herein provided.

 

		(v)	All
                                            voting rights with respect to Shares held in trust shall be given to the Trustee, who will
                                            exercise them only if instructed to do so by the Board and in accordance with such instructions.

 

		(d)	Subject
                                            to the terms hereof, at any time after the Trust Period, with respect to any Options or Shares
                                            the following shall apply: upon the written request of any Beneficial Participant, the Trustee
                                            shall release from the Trust the Options granted, and/or the Shares issued, on behalf of
                                            such Beneficial Participant, by executing and delivering to the Corporation such instrument(s)
                                            as the Corporation may require, giving due notice of such release to such Beneficial Participant,
                                            provided, however, that the Trustee shall not so release any such Options or Shares to such
                                            Beneficial Participant unless the latter, prior to, or concurrently with, such release, provides
                                            the Trustee with evidence, satisfactory in form and substance to the Trustee, that all taxes,
                                            if any, required to be paid upon such release have, in fact, been paid.

 

	4.	Guarantee

 

In
the event a 102(c) Option is granted to a 102 Participant who is an employee at the time of such grant, if the Participant’s employment
is terminated, for any reason, and should such option continue to be valid in accordance with this Plan, such 102 Participant shall provide
the Corporation with a guarantee or collateral securing the payment of all taxes required to be paid upon the sale of the Exercised Shares
received upon exercise of such 102(c) Option.

 

	5.	Dividend
                                            

 

For
so long as Shares issued to the Trustee on behalf of a Beneficial Participant are held in the Trust, the dividends paid or distributed
with respect thereto shall be remitted to the Trustee for the benefit of such Beneficial Participant or distributed directly to such
Beneficial Participant, as shall be solely determined by the Board.Exhibit 4.14

 

	[Stamp]
                                            State of Israel

    Israeli
    Medical Cannabis Agency

    (IMCA)
	 	[logo]
                                            [emblem of the State of Israel

    Ministry
    of Health

    [illegible]

    Medical
    Cannabis Agency
	 	 

     

     

    Valid
    until: October 20, 2022

    Dealer's
    Code: V-1315-060518

 

Initial
Authorization to Establish a Site for Dealing with a Controlled Substance

 

By
virtue of the authority vested in me pursuant to Sections 6, 7 and 13 in the middle of the Dangerous Drugs Ordinance [New Version], 5733
– 1973 (hereinafter “the Ordinance”) and pursuant to the Dangerous Drugs Regulations, 5739 – 1979 (hereinafter:
“the Regulations”), an initial authorization is hereby granted to establish a proliferation farm – proliferation of
cannabis plants (hereinafter “the site”) and, according to the following detail:

 

	1.	The
                                            Applicant for the Authorization and his Details:

 

	1.1
                                                                     Name of the entrepreneur/Corporation: Dalia Bezizinsky

    1.2
    Site Address: Kochav Michael

    1.3
    Contact Person (Name): Dalia Bezizinsky
	ID/Co
No: 054771613: (hereinafter: “the applicant”)

    Farm/Estate:
    Form Number 10

    ID
    No: 054771613 Tel No: 054-222-8861

 

	2.	Name
                                            of the Controlled Substance

 

CANNABIS

 

	3.	Its
                                            Form

 

This
approval does not constitute approval for possession in any form

It
is absolutely prohibited to possess the drug, plant, any part of it, its components or products and in any form for as long as no express
license for this is been received from the Director.

 

	4.	The
                                            Purpose of the Approval

 

		4.1	To
                                            act for planning/establishing/adapting a proliferation farm – proliferation of
                                            the cannabis plant

		4.2	The
                                            applicant declares that this approval will not be used for any purpose not approved and specified
                                            expressly in this approval.

 

	5.	Restrictions
                                            and Additional Conditions:

 

		5.1	This
                                            approval is only temporary. This approval can be annulled pursuant to the Director’s
                                            sole discretion, or pursuant to a Government of Israel decision, without derogating from
                                            any other cause in the law for annulling the approval.

		5.2	This
                                            approval contains nothing to impose any obligation whatsoever on the Ministry of Health or
                                            the Medical Cannabis Agency to grant a license for dealing in a controlled substance.

		5.3	This
                                            approval is approval for the applicant to commence establishing or adapting the site pursuant
                                            to the designated occupation. The principles of the planning and establishment/adaptation
                                            of the business must be executed pursuant to the designated occupation, while complying with
                                            all the relevant requirements of the law and pursuant to quality and security requirements
                                            as detailed below:

		a.	Cultivation
                                            or proliferation of the cannabis plants – as detailed in Procedure IMC-GAP (proper
                                            cultivation conditions) and as detailed in Procedure IMC GSP (security conditions).

 

It
must be emphasized: The applicant must comply with the security requirements as detailed in Procedure IMC-GSP at the site and must receive
security approval pursuant to the type of occupation.

 

		5.4	This
                                            approval cannot be transferred in any form whatsoever.

		5.5	Should
                                            there be any change whatsoever in the ownership of the applicant, or in the identity of the
                                            controlling shareholders therein, or in its managers or authorized signatories, who are detailed
                                            in this license without receiving the advance written approval of the IMCA for this –
                                            the validity of the license will expire. Regarding this section, a change in the ownership
                                            means transferring shares, in any manner whatsoever, in a volume that exceeds 5% of the Company’s
                                            total share capital.

 

[signature]

[stamp]
MGR Yuval Landschaft

L.N.
4023

Director

the
Medical Cannabis Agency (IMCA)

	Israel
                                            Medical Cannabis Agency

    Minister
    Health

    PO
    Box 1176 Jerusalem 91010

    IMCA@moh.health.gov.il

    Tel
    No *5400 Fax No: 02-647-4810
	 	Kol
                                            Habriut

    *5400
	 	[bilingual
    text see left column]

 

    	 

     

    

 

	[Stamp]
                                            State of Israel

    Israeli
    Medical Cannabis Agency

    (IMCA)
	 	[logo]
                                            [emblem of the State of Israel

    Ministry
    of Health

    [illegible]

    Medical
    Cannabis Agency
	 	 

     

     

    Valid
    until: October 20, 2022

    Dealer's
    Code: V-1315-060518

 

		5.6	In
                                            view of the activity in the cannabis field, and because this activity obligates, inter alia,
                                            receipt of the IMCA’s approval for all the dealers, managers and interested parties
                                            in companies and/or their managers – granting the initial authorization/the license
                                            is subject to the attached conditions:

 

		a.	Any
                                            material shareholder as defined in the Company’s capital, 5759 – 1999 and/or
                                            controlling shareholder as defined in the Company’s capital 5759 – 1999 and/or
                                            any effective controlling shareholder and/or Director and/or General Manager in the Company,
                                            has to receive the IMCA’s approval.

		b.	No
                                            shares in the Company may be transferred to any offeree whatsoever when, following this allocation,
                                            he will become an interested party, prior to the IMCA’s approval for this after receiving
                                            a recommendation from a competent official.

		c.	No
                                            Director and/or General Manager may be appointed in the Company prior to receiving the IMCA’s
                                            approval for this, after receiving a recommendation from a competent official. This

		d.	The
                                            Company must amend its Articles of Association so that they include an instruction pursuant
                                            to which if any entity/entities whatsoever becomes/become an interested party/interested
                                            parties in the Company by virtue of his/their shareholding or an agreement between the shareholders,
                                            prior to receiving the mandatory approvals from the IMCA, the Company shall have the right
                                            to confiscate and/or make some of the shares held by one or more of these shareholders dormant
                                            so that after the confiscation and/or making the shares dormant the entity/entities will
                                            no longer be interested parties by virtue of the holdings or by virtue of agreement in the
                                            Company.

d1.
An entity/entities, whose shares have been made dormant, should they be made dormant, shall, at any time, have the right to sell or transfer
all or some of these shares to another/others, subject to the details in this Procedure and the requirements of the Ordinance and the
Law.

		e.	The
                                            Company will not extend the appointment of a Director or its General Manager, unless at the
                                            date of the extension there is approval from the IMCA in this regard, after receiving a repeat
                                            recommendation from a competent official.

		f.	At
                                            every Annual Meeting of the Company, the General Manager of the Company must declare that
                                            all the approval/approvals required from the IMCA for the Company, the manager/managers and
                                            the interested party/parties, as detailed in Sections a, b, and c above as at the date of
                                            the meeting, are available and valid and there has not been any change in the status of the
                                            Company, the managers/managers, material shareholder/shareholders and the interested party/parties
                                            from the date of being granted the authorization/authorizations

 

		5.7	The
                                            applicant must inform the Director immediately of any change in any of his details (his address,
                                            contact persons etc.) and must receive the IMCA’s advance written approval for any
                                            change in the ownership of the applicant or in the identity of the interested parties or
                                            its managers or its authorized signatories or the material shareholders.

		5.8	The
                                            presence of minors at the site or installation is absolutely prohibited.

		5.9	The
                                            instructions in the ordinance and regulations and any instruction and/or stipulation for
                                            complying with any of the quality conditions required shall apply to the applicant.

		5.10	The
                                            applicant must keep a regular record of all the actions regarding the establishment of the
                                            site and any additional record required by the Director.

The
records must be presented to the Director whenever he requires this and must also be presented to any other competent entity according
to the matter pursuant to the demand of the Director.

		5.11	These
                                            conditions and stipulations can be updated at the IMCA’s sole discretion and with approval
                                            of the Director General of the Ministry of Health. The IMCA is entitled to publish additional
                                            instructions pursuant to the circumstances and essence of the occupation.

 

	6.	The
                                            Validity of the Approval

 

		6.1	This
                                            approval annuls any other or additional previous approval in the possession of the applicant.

		6.2	This
                                            approval was granted on October 20, 2021 at the offices of the IMCA

		6.3	The
                                            validity of this approval expires on October 20, 2022, unless it is annulled
                                            previously to this at the decision of the Director.

 

Yuval
Landschaft

The
Director pursuant to the Dangerous Drugs Ordinance

 

[signature]

[stamp]
MGR Yuval Landschaft

L.N.
4023

Director

the
Medical Cannabis Agency (IMCA)

	Israel
                                            Medical Cannabis Agency

    Minister
    Health

    PO
    Box 1176 Jerusalem 91010

    IMCA@moh.health.gov.il

    Tel
    No *5400 Fax No: 02-647-4810
	 	Kol
                                            Habriut

    *5400
	 	[bilingual
    text see left column]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]